Sample | Title | Value | Rank |
GSM967852 | U87-EV human glioblastoma xenograft - Control 1 | 2.17122 | 7 |
GSM967853 | U87-EV human glioblastoma xenograft - Control 2 | 2.13541 | 7 |
GSM967854 | U87-EV human glioblastoma xenograft - Control 3 | 2.13806 | 7 |
GSM967855 | U87-EV human glioblastoma xenograft - Control 4 | 2.08398 | 6 |
GSM967856 | U87-EV human glioblastoma xenograft - Control 5 | 2.07511 | 6 |
GSM967862 | U87-EV human glioblastoma xenograft - Bevacizumab treated 1 | 2.18596 | 7 |
GSM967863 | U87-EV human glioblastoma xenograft - Bevacizumab treated 2 | 2.13325 | 6 |
GSM967864 | U87-EV human glioblastoma xenograft - Bevacizumab treated 3 | 2.11757 | 6 |
GSM967865 | U87-EV human glioblastoma xenograft - Bevacizumab treated 4 | 2.11577 | 7 |
GSM967857 | U87-EV human glioblastoma xenograft - dibenzazepine treated 1 | 2.12062 | 6 |
GSM967858 | U87-EV human glioblastoma xenograft - dibenzazepine treated 2 | 2.12006 | 6 |
GSM967859 | U87-EV human glioblastoma xenograft - dibenzazepine treated 3 | 2.10758 | 6 |
GSM967860 | U87-EV human glioblastoma xenograft - dibenzazepine treated 4 | 2.12594 | 6 |
GSM967861 | U87-EV human glioblastoma xenograft - dibenzazepine treated 5 | 2.12626 | 6 |